bullish

Takeda Offloads Asia-Focused Drugs to South Korea’s Celltrion

367 Views12 Jun 2020 16:26
The Japanese drug maker, Takeda Pharmaceutical (4502 JP)  announced yesterday (11th June 2020) that it has entered into an agreement to divest a...
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top Quartile
Shifara Samsudeen, ACMA, CGMA
Equity Analyst
LightStream Research
JapanIndustrialsEquity Bottom-UpEquity Capital Markets
Price Chart(Sign Up to Access)
analytics-chart
x